These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 14568807
1. Increased risk of stroke in hypertensive women using hormone therapy: analyses based on the Danish Nurse Study. Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Hundrup YA, Obel EB, Pedersen AT. Arch Neurol; 2003 Oct; 60(10):1379-84. PubMed ID: 14568807 [Abstract] [Full Text] [Related]
2. Menopause and stroke and the effects of hormonal therapy. Lobo RA. Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669 [Abstract] [Full Text] [Related]
3. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. Løkkegaard E, Jovanovic Z, Heitmann BL, Keiding N, Ottesen B, Pedersen AT. Maturitas; 2006 Jan 20; 53(2):226-33. PubMed ID: 15955642 [Abstract] [Full Text] [Related]
4. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. N Engl J Med; 1991 Sep 12; 325(11):756-62. PubMed ID: 1870648 [Abstract] [Full Text] [Related]
5. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Arch Intern Med; 1993 Jan 11; 153(1):73-9. PubMed ID: 8422201 [Abstract] [Full Text] [Related]
6. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. Holmberg L, Iversen OE, Rudenstam CM, Hammar M, Kumpulainen E, Jaskiewicz J, Jassem J, Dobaczewska D, Fjosne HE, Peralta O, Arriagada R, Holmqvist M, Maenpaa J, HABITS Study Group. J Natl Cancer Inst; 2008 Apr 02; 100(7):475-82. PubMed ID: 18364505 [Abstract] [Full Text] [Related]
7. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C. Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651 [Abstract] [Full Text] [Related]
8. A clinical trial of estrogen-replacement therapy after ischemic stroke. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI. N Engl J Med; 2001 Oct 25; 345(17):1243-9. PubMed ID: 11680444 [Abstract] [Full Text] [Related]
9. Cardiovascular risk factors in a cohort of Danish women born in 1936 prior to use of hormone therapy. Løkkegaard E, Eplov LF, Køster A, Garde K. Maturitas; 2005 Jul 16; 51(3):221-6. PubMed ID: 15950410 [Abstract] [Full Text] [Related]
10. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. Grodstein F, Manson JE, Stampfer MJ. J Womens Health (Larchmt); 2006 Jul 16; 15(1):35-44. PubMed ID: 16417416 [Abstract] [Full Text] [Related]
11. Risk of stroke and hormone replacement therapy. A prospective cohort study. Li C, Engström G, Hedblad B, Berglund G, Janzon L. Maturitas; 2006 Apr 20; 54(1):11-8. PubMed ID: 16321486 [Abstract] [Full Text] [Related]
12. Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women. Graff-Iversen S, Hammar N, Thelle DS, Tonstad S. J Intern Med; 2004 Nov 20; 256(5):437-45. PubMed ID: 15485480 [Abstract] [Full Text] [Related]
13. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Glud E, Kjaer SK, Thomsen BL, Høgdall C, Christensen L, Høgdall E, Bock JE, Blaakaer J. Arch Intern Med; 2004 Nov 08; 164(20):2253-9. PubMed ID: 15534163 [Abstract] [Full Text] [Related]
14. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease. Windler E, Zyriax BC, Eidenmüller B, Boeing H. Maturitas; 2007 Jul 20; 57(3):239-46. PubMed ID: 17292571 [Abstract] [Full Text] [Related]
15. The effects of awareness, treatment and control of hypertension on future stroke incidence in a community-based population study in Finland. Barengo NC, Hu G, Kastarinen M, Antikainen R, Tuomilehto J. J Hypertens; 2009 Jul 20; 27(7):1459-65. PubMed ID: 19365282 [Abstract] [Full Text] [Related]
16. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Alexandersen P, Tankó LB, Bagger YZ, Qin G, Christiansen C. Climacteric; 2006 Apr 20; 9(2):108-18. PubMed ID: 16698657 [Abstract] [Full Text] [Related]
17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE. J Natl Cancer Inst; 2005 Apr 20; 97(8):595-602. PubMed ID: 15840882 [Abstract] [Full Text] [Related]
18. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study. Tetsche MS, Jacobsen J, Nørgaard M, Baron JA, Sørensen HT. Am J Gastroenterol; 2007 Feb 20; 102(2):275-8. PubMed ID: 17311649 [Abstract] [Full Text] [Related]
19. Hormone therapy and risk of myocardial infarction: a national register study. Løkkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard Ø. Eur Heart J; 2008 Nov 20; 29(21):2660-8. PubMed ID: 18826989 [Abstract] [Full Text] [Related]
20. Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Yates J, Barrett-Connor E, Barlas S, Chen YT, Miller PD, Siris ES. Obstet Gynecol; 2004 Mar 20; 103(3):440-6. PubMed ID: 14990403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]